SPARK TEL AVIV GRANTS
2021 Call for Proposals
SPARK program offers grants for the development of novel therapeutics (small molecule or biologic) and diagnostics for unmet medical needs. Projects receive funding for up to two years and mentorship from experts in all areas of drug development.
Proposals will be evaluated based on the following criteria:
- Scope of unmet clinical need
- Novelty of approach
- Feasibility (budget and time)
- Quality and data
- Team suitability
- Marketability/probability of commercialization
All proposals must be submitted by November 15, 2020, in English. The proposal should be sent electronically to email: email@example.com. Proposals submitted later than this deadline will not be reviewed.
Amount and Period of Funding:
Admitted projects receive milestone-based funds to support and de-risk each project, up to 100,000$ per project/year, a maximum of two years based on the accomplishment of milestones. Awards will be granted for the period from March 1, 2021 through February 31, 2022.
SPARK accepts product proposals for any clinical indication from TAU researchers. This includes researches, postdoctoral scholars, and graduate students. Graduate students, postdoctoral scholars are encouraged to apply and are required to include a PI eligible faculty member as Co-PI on the application.
Priority will be given to teams that include both researchers (TAU) and physicians (affiliated hospitals).
Research projects funded by the Israel Innovation Authority can apply for the mentoring program but are not eligible for funding.
Proposals received online will be reviewed by a selection committee composed of Tel-Aviv faculty and industry experts. Based on the compiled rankings, finalists will be invited to present an oral pitch to the review panel. This session will take place in January 2021 (TBD).
To apply for a SPARK Grant, please complete and submit online application below.
If you have any questions, please contact SPARK Program Manager: Dr. Inbal Hazan-Halevy | firstname.lastname@example.org